ML20246K382

From kanterella
Jump to navigation Jump to search
Amend 4 to License SNM-1365 for Veterans Admin Medical Ctr, Amending License in Entirety
ML20246K382
Person / Time
Site: 07001401
Issue date: 03/06/1989
From: Cain C
NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION IV)
To:
Shared Package
ML20246K387 List:
References
NUDOCS 8903210580
Download: ML20246K382 (2)


Text

-- _ _ - _ _ _ _ _ _ _ _ _ - _ _ _ _ _ _ _ _ _ _ _

pmm-----------m---------mmmmm.. - mmmmmmmmm---_

] NRC Form 374 PA GE ] OF 2 PAGES g

j (5 847> U.S. NUCLEAR REGULATORY COMMISSION

( Amendment No. 04 1 MATERIALS LICENSE Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, jl Code of Federal Regulations, Chapter 1, Parts 30,31,32,33,34,35,40 and 70, and in reliance on statements and representations y s heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, i source, and special nuclear material designated below; to use such material for the purpose (s) and at the place (s) designated below; to

! deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This

license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is
subject to all applicable rules, regulations and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any 3 conditions specified below.

u j Licensee In accordance with letter dated 1 May 26, 1988'

't. Veterans Administration Medical Center 3. License number SNM-1365 is amended in its b entirety to read as follows:

4

] '

2. 4500 South Lancaster Road Dallas, Texas 75216
4. Expiration date March 31, 1994 l]

i lI 5. Docket or 070-01401 j

Reference No.

j 6. Byproduct, source, and/or 7. Chemical and/or physical 8. Maximum amount that licensee i special nuclear material form may possess at any one time f

j under this license j j A. Plutonium (Principal A. Sealed Source A. One source not to i jj radionuclides Pu-238) exceed j ll 210 milligrams U

y 9. Authorized use .

Ji l fl A. As a cerrponent of Medtronic Model 9000 nuclear-powered pacemaker for clinical  ;

j  ; evaluation purposes. This license authorizes possessien of the pacemaker for y purposes of explanation, recovery and disposal, but not for implantation.

U H CONDITIONS i t

l:l 10. Licensed materici shall be used only at Veterans Administration Medical Center, O 4500 South Lancaster Road, Dallas, Texas.

b ,f E

p 11. The specified possession limit includes all licensed material possessed by the licensee under this license whether in storage, implanted in patients or otherwise in i p

[ use.

L 12, The licensee shall not receive or transfer in any single transaction, 1 gram or more of plutonium-238 contained in nuclear-powered pacemakers without notifying the i

[ Division of Safeguards, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555,  !

c and, in addition, completing and distributing Form NRC-741 as required by Section 70.54 of 10 CFR Part 70.

l L 8903210580 890306 ,

i REG 4 LIC70 PNV I

SNM-1365 ,

--E

?

l. , . . . . . . . . , ,, ,,.. , . . . . . . . <, , , , , , , . . . . . . . , . . , , , . . . . , , . , . , , , , . . . , . . , , , , , , , , , , , , , , , , , . , + . , , , , , , , , , , . , . , . , , , , , , ,g l Nxcpm 3MA ' U.S. NUCLEAR RE2ULATORY COMMISSION PAGE OF PAGES  !

l 8084 , License number I p SNM-1365 1

  • MATERIALS LICENSE oocket or nererence number I SUPPLEMENTARY SHEET 8 070-01401 5

Amendment No. 04 l l

E lq 13. The licensee shall report to the fledical, Academic, and Commercial Use Safety N

y q Branch, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, within 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> N q of occurrence, the death of any nuclear pacemaker patient, and any adverse reaction N N and/or malfunction involving a pacemaker system, including the leads. A written N I report giving details of the adverse reaction and/or malfunction shall be submitted l within 30 days.

l y

14. The licensee shall report to the liedical, Academic, and Commercial Use Safety W Branch, U.S. Nuclear Regulatory Commission, Washington, D.C. 20555, within 10 days, i I loss of contact with a. nuclear pacemaker patient.

l l 15. The licensee shall continue patient follow-up and replacement procedures for the l y nuclear pacemaker during the life of the patient; and procedures for recovery and p g authorized disposal of the nuclear pacemaker by return to the manufacturer shall be R i followed upon the death of the patient. >

N N lg 16. Except as specifically provided otherwise in this license, tfie licensee shall E conduct its program in accordance with the statements, representations, and a procedures contained in the documents, including any enclosures, listed below.

N The Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence I are more restrictive than the regulations. j i A. Letter dated June 1, 1973 g

Letter dated liay 3,1974 l N B. .

$ C. Letter dated May 25, 1983

$ D. Letter dated May 26, 1988 ,

N N I N

N l l

4 j3 N l' l l

l l A f A B N

M p

4 - R 4 i k

  1. FOR THE U.S. NUCLEAR REGULATORY COMMISSION l>

lE t@,R 61939 Original signed by I

{

Ml Date -~

By n L. Cain I W Nucle- ials Licensing Section .f omcw.aecoac wy 't -

as 76011 #/ k

! 6 )  !

L L__ _ _ _ _ _ _ _ m m - m m , _ m - ~ 4'1 1

1 j

1